GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » Stock Based Compensation

Bora Pharmaceuticals Co (TPE:6472) Stock Based Compensation : NT$136 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co Stock Based Compensation?

Bora Pharmaceuticals Co's Stock Based Compensation for the three months ended in Dec. 2024 was NT$33 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was NT$136 Mil.


Bora Pharmaceuticals Co Stock Based Compensation Historical Data

The historical data trend for Bora Pharmaceuticals Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bora Pharmaceuticals Co Stock Based Compensation Chart

Bora Pharmaceuticals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.71 15.77 31.83 102.81 135.98

Bora Pharmaceuticals Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.41 43.76 26.50 33.22 32.51

Bora Pharmaceuticals Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$136 Mil.


Bora Pharmaceuticals Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bora Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines